W. Zoli et al., A NEW CELL-LINE FROM HUMAN INFILTRATING DUCTAL CARCINOMA OF THE BREAST - ESTABLISHMENT AND CHARACTERIZATION, Journal of cancer research and clinical oncology, 122(4), 1996, pp. 237-242
We established a novel cancer cell line (MAST) from the ascitic fluid
of a metastatic infiltrating ductal carcinoma of the breast. The epith
elial and neoplastic nature of the MAST cells was confirmed by ultrast
ructural analysis. The cell line was maintained as a monolayer with a
doubling time of about 68 h, and it possessed an abnormal karyotype wi
th a modal chromosome number of 60, a trisomy of chromosome 18 and oth
er unidentified rearranged chromosomes. Among the markers consistently
found in MAST metaphases, we noted a t(14; 14) and a very large subte
locentric, a large satellited acrocentric and a very large submetacent
ric chromosome with striking fluorescent bands. Immunoenzymatic assay
demonstrated that the MAST cell line was positive for estrogen and pro
gesterone receptors. The in vitro drug-sensitivity assay showed a mark
ed resistance of the cell line to 5-fluorouracil and 4-hydroperoxycycl
ophosphamide and a moderate resistance to etoposide and 4'-epidoxo-rub
icin. The molecular analysis showed a four- to sixfold amplification o
f the c-myc gene and no amplification or rearrangement of the int-2, c
-erbB-2, c-Ha-ras, c-mos and hst-1 genes.